Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1Breast 1

Conditions

Melanoma 1Central Nervous System Diseases 1Breast Neoplasms 1Brain Neoplasms 1

Interventions

Temozolomide 2Sodium Chloride 2Dexmedetomidine 2tucatinib 1tipifarnib 1sagopilone 1pembrolizumab 1Trastuzumab 1Tissue Banks 1Saline Solution 1Rituximab 1Radiotherapy 1Radiation 1Dasatinib 1Bevacizumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Central Nervous System Diseases × sagopilone × Clear all
NCT00496379 2013-03-14

ZK219477 (Sagopilone) in Patients With Breast Cancer and Brain Metastases

Dana-Farber Cancer Institute

Phase 2 Terminated
15 enrolled 10 charts
BreastCNS

Brain Neoplasms, Breast Neoplasms, Central Nervous System Diseases

Data powered by HemOnc (CC BY 4.0) Colophon âš¡